BUZZ-Ceribell jumps on FDA clearance of brain monitoring device
Reuters
Dec 09, 2025
BUZZ-<a href="https://laohu8.com/S/CBLL">Ceribell</a> jumps on FDA clearance of brain monitoring device
** Shares of medical device maker Ceribell CBLL.O rise 10.5% to $22.33
** Co says the U.S. FDA cleared its screening and monitoring device to assist in diagnosing patients at risk for both seizures and delirium
** Delirium is a potential indicator for life-threatening conditions and is defined as a mental state characterized by confusion, disorientation, and reduced awareness of surroundings
** Ceribell's device uses an AI-powered software algorithm to analyze brain activity that is associated with delirium
** Up to last close, stock down 21.9% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.